CAC
Core Alternative Capital’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Sell |
280
-2,772
| -91% | -$515K | 0.01% | 123 |
|
|
2025
Q1 | $639K | Sell |
3,052
-82
| -3% | -$17.2K | 0.15% | 78 |
|
|
2024
Q4 | $557K | Sell |
3,134
-803
| -20% | -$143K | 0.12% | 83 |
|
|
2024
Q3 | $777K | Buy |
3,937
+150
| +4% | +$29.6K | 0.15% | 74 |
|
|
2024
Q2 | $650K | Sell |
3,787
-8
| -0.2% | -$1.37K | 0.13% | 78 |
|
|
2024
Q1 | $691K | Sell |
3,795
-772
| -17% | -$141K | 0.12% | 75 |
|
|
2023
Q4 | $708K | Sell |
4,567
-1,018
| -18% | -$158K | 0.12% | 75 |
|
|
2023
Q3 | $833K | Buy |
5,585
+2,988
| +115% | +$445K | 0.13% | 76 |
|
|
2023
Q2 | $350K | Buy |
2,597
+176
| +7% | +$23.7K | 0.05% | 81 |
|
|
2023
Q1 | $386K | Buy |
2,421
+90
| +4% | +$14.3K | 0.05% | 77 |
|
|
2022
Q4 | $377K | Sell |
2,331
-401
| -15% | -$64.8K | 0.05% | 86 |
|
|
2022
Q3 | $367K | Sell |
2,732
-156
| -5% | -$21K | 0.06% | 81 |
|
|
2022
Q2 | $442K | Buy |
2,888
+1,080
| +60% | +$165K | 0.1% | 88 |
|
|
2022
Q1 | $293K | Buy |
1,808
+1,490
| +469% | +$241K | 0.08% | 90 |
|
|
2021
Q4 | $43K | Buy |
318
+60
| +23% | +$8.11K | 0.01% | 121 |
|
|
2021
Q3 | $28K | Buy |
+258
| New | +$28K | 0.01% | 82 |
|